Literature DB >> 6390911

Diagnostic imaging of urothelial cancer.

E J Lantz, R R Hattery.   

Abstract

Technologic advances in diagnostic imaging offer new ways to evaluate urothelial tumors. Computed tomography, ultrasound, and magnetic resonance imaging each have potential to provide information previously unavailable without surgical intervention.

Entities:  

Mesh：

Year:  1984        PMID： 6390911

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  6 in total

1.  Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer.

Authors:  S Kosuda; P V Kison; R Greenough; H B Grossman; R L Wahl
Journal:  Eur J Nucl Med       Date:  1997-06

Review 2.  [Value of positron emission tomography in urological neoplasms: more form than substance?].

Authors:  J Müller; M Schrader; A J Schrader; M Höpfner; F Zengerling
Journal:  Urologe A       Date:  2012-03       Impact factor: 0.639

3.  Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma.

Authors:  Adam S Kibel; Farrokh Dehdashti; Matthew D Katz; Aleksandra P Klim; Robert L Grubb; Peter A Humphrey; Cary Siegel; Dengfeng Cao; Feng Gao; Barry A Siegel
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

4.  Role of consolidative surgical therapy in patients with locally advanced or regionally metastatic bladder cancer.

Authors:  Mark D Tyson; Sam S Chang; Kirk A Keegan
Journal:  Bladder (San Franc)       Date:  2016

Review 5.  Imaging in genitourinary cancer from the urologists' perspective.

Authors:  P Tsakiris; J de la Rosette
Journal:  Cancer Imaging       Date:  2007-05-28       Impact factor: 3.909

6.  Role of fluorodeoxyglucose positron emission tomography/computed tomography in diagnostic evaluation of carcinoma urinary bladder: comparison with computed tomography.

Authors:  Dhritiman Chakraborty; Bhagwant Rai Mittal; Raghava Kashyap; Utham Kumar Mete; Vikram Narang; Ashim Das; Anish Bhattacharya; Niranjan Khandelwal; Arup K Mandal
Journal:  World J Nucl Med       Date:  2014-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.